<code id='E635E44B20'></code><style id='E635E44B20'></style>
    • <acronym id='E635E44B20'></acronym>
      <center id='E635E44B20'><center id='E635E44B20'><tfoot id='E635E44B20'></tfoot></center><abbr id='E635E44B20'><dir id='E635E44B20'><tfoot id='E635E44B20'></tfoot><noframes id='E635E44B20'>

    • <optgroup id='E635E44B20'><strike id='E635E44B20'><sup id='E635E44B20'></sup></strike><code id='E635E44B20'></code></optgroup>
        1. <b id='E635E44B20'><label id='E635E44B20'><select id='E635E44B20'><dt id='E635E44B20'><span id='E635E44B20'></span></dt></select></label></b><u id='E635E44B20'></u>
          <i id='E635E44B20'><strike id='E635E44B20'><tt id='E635E44B20'><pre id='E635E44B20'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:99
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Getting Alzheimer's drug Leqembi to patients can be a challenge
          Getting Alzheimer's drug Leqembi to patients can be a challenge

          BenMargot/APAhostofhurdlesareslowingtheadoptionofthenewAlzheimer’sdrugLeqembi,expertsinvolvedinthetr

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          It's time to get medical device identifiers over the finish line

          Addingidentifiersformedicaldeviceslikepacemakerstoclaimsformswouldhelpimprovedevicesafety.SEBASTIENB